To test this hypothesis, we chose as a model system prostate cancer because hyperactivation of the PI3K-AKT-mTOR pathway has been associated with disease progression from the primary to metastatic phase and carboxymethyl sensitive PP2A regulatory subunits regulates this pathway24,37,38. This evidence concerns the gene PTPA and prostate cancer.